Subdural hematoma in glutaric aciduria type 1: High excreters are prone to incidental SDH despite newborn screening. 2021

Nikolas Boy, and Alexander Mohr, and Sven F Garbade, and Peter Freisinger, and Jana Heringer-Seifert, and Angelika Seitz, and Stefan Kölker, and Inga Harting
Centre for Child and Adolescent Medicine, Clinic I, Division of Child Neurology and Metabolic Medicine, Heidelberg University Hospital, Heidelberg, Germany.

Subdural hematoma (SDH) was initially reported in 20% to 30% of patients with glutaric aciduria type 1 (GA1). A recent retrospective study found SDH in 4% of patients, but not in patients identified by newborn screening (NBS). 168 MRIs of 69 patients with GA1 (age at MRI 9 days - 73.8 years, median 3.2 years) were systematically reviewed for presence of SDH, additional MR and clinical findings in order to investigate the frequency of SDH and potential risk factors. SDH was observed in eight high-excreting patients imaged between 5.8 and 24.4 months, namely space-occupying SDH in two patients after minor accidental trauma and SDH as an incidental finding in six patients without trauma. In patients without trauma imaged at 3 to 30 months (n = 36, 25 NBS, 27/9 high/low excreters), incidence of SDH was 16.7% (16% in NBS). SDH was more common after acute (33.3%) than insidious onset of dystonia (14.3%) or in asymptomatic patients (5.9%). It was only seen in patients with wide frontoparietal CSF spaces and frontotemporal hypoplasia. High excreters were over-represented among patients with SDH (6/27 vs 0/9 low excreters), acute onset (10/12), and wide frontoparietal CSF spaces (16/19). Incidental SDH occurs despite NBS and early treatment in approximately one in six patients with GA1 imaged during late infancy and early childhood. Greater risk of high excreters is morphologically associated with more frequent enlargement of external CSF spaces including frontotemporal hypoplasia, and may be furthered aggravated by more pronounced alterations of cerebral blood volume and venous pressure.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001928 Brain Diseases, Metabolic Acquired or inborn metabolic diseases that produce brain dysfunction or damage. These include primary (i.e., disorders intrinsic to the brain) and secondary (i.e., extracranial) metabolic conditions that adversely affect cerebral function. Central Nervous System Metabolic Disorders,Encephalopathies, Metabolic,Metabolic Disorders, Brain,Acquired Metabolic Diseases, Brain,Acquired Metabolic Diseases, Nervous System,Acquired Metabolic Encephalopathies,Brain Diseases, Metabolic, Acquired,Brain Disorders, Metabolic,Brain Disorders, Metabolic, Acquired,Brain Syndrome, Metabolic,Brain Syndrome, Metabolic, Acquired,CNS Metabolic Disorders,CNS Metabolic Disorders, Acquired,Encephalopathy, Metabolic, Acquired,Metabolic Brain Diseases,Metabolic Brain Diseases, Acquired,Metabolic Brain Syndrome,Metabolic Brain Syndrome, Acquired,Metabolic Brain Syndromes,Metabolic Brain Syndromes, Acquired,Metabolic Diseases, Acquired, Nervous System,Metabolic Disorder, Central Nervous System, Acquired,Metabolic Disorders, CNS,Metabolic Disorders, CNS, Acquired,Metabolic Disorders, Central Nervous System,Metabolic Encephalopathies,Nervous System Acquired Metabolic Diseases,Acquired Metabolic Encephalopathy,Brain Disease, Metabolic,Brain Disorder, Metabolic,Brain Metabolic Disorder,Brain Metabolic Disorders,CNS Metabolic Disorder,Encephalopathies, Acquired Metabolic,Encephalopathy, Acquired Metabolic,Encephalopathy, Metabolic,Metabolic Brain Disease,Metabolic Brain Disorder,Metabolic Brain Disorders,Metabolic Disorder, Brain,Metabolic Disorder, CNS,Metabolic Encephalopathies, Acquired,Metabolic Encephalopathy,Metabolic Encephalopathy, Acquired
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females

Related Publications

Nikolas Boy, and Alexander Mohr, and Sven F Garbade, and Peter Freisinger, and Jana Heringer-Seifert, and Angelika Seitz, and Stefan Kölker, and Inga Harting
January 1993, Brain & development,
Nikolas Boy, and Alexander Mohr, and Sven F Garbade, and Peter Freisinger, and Jana Heringer-Seifert, and Angelika Seitz, and Stefan Kölker, and Inga Harting
January 1993, Brain & development,
Nikolas Boy, and Alexander Mohr, and Sven F Garbade, and Peter Freisinger, and Jana Heringer-Seifert, and Angelika Seitz, and Stefan Kölker, and Inga Harting
August 2012, Journal of paediatrics and child health,
Nikolas Boy, and Alexander Mohr, and Sven F Garbade, and Peter Freisinger, and Jana Heringer-Seifert, and Angelika Seitz, and Stefan Kölker, and Inga Harting
January 2008, Molecular genetics and metabolism,
Nikolas Boy, and Alexander Mohr, and Sven F Garbade, and Peter Freisinger, and Jana Heringer-Seifert, and Angelika Seitz, and Stefan Kölker, and Inga Harting
May 2018, Annals of neurology,
Nikolas Boy, and Alexander Mohr, and Sven F Garbade, and Peter Freisinger, and Jana Heringer-Seifert, and Angelika Seitz, and Stefan Kölker, and Inga Harting
February 2001, Pediatrics,
Nikolas Boy, and Alexander Mohr, and Sven F Garbade, and Peter Freisinger, and Jana Heringer-Seifert, and Angelika Seitz, and Stefan Kölker, and Inga Harting
July 2016, European journal of pediatrics,
Nikolas Boy, and Alexander Mohr, and Sven F Garbade, and Peter Freisinger, and Jana Heringer-Seifert, and Angelika Seitz, and Stefan Kölker, and Inga Harting
November 2023, Radiographics : a review publication of the Radiological Society of North America, Inc,
Nikolas Boy, and Alexander Mohr, and Sven F Garbade, and Peter Freisinger, and Jana Heringer-Seifert, and Angelika Seitz, and Stefan Kölker, and Inga Harting
January 2001, Ryoikibetsu shokogun shirizu,
Nikolas Boy, and Alexander Mohr, and Sven F Garbade, and Peter Freisinger, and Jana Heringer-Seifert, and Angelika Seitz, and Stefan Kölker, and Inga Harting
August 2008, Journal of inherited metabolic disease,
Copied contents to your clipboard!